Embedded Files
TriageIQ™ | Universal Chronic Screener. Every Adult.
Company Overview
Diabetes Creates Damage. We Find the Risks Early.
Diabetes Testing Centers™ (DTC) exists to shift healthcare from reactive treatment to proactive prevention by making early detection of chronic disease simple, non-invasive, and reimbursable. We empower providers to identify risk before irreversible damage occurs—so patients have a real chance to live longer, healthier lives and make it home safely each day.
Who We Are
Chronic Risk Assessments by DTC was founded by former family practice owners with over 30 years of combined clinical and Fortune 5 business experience. Built from firsthand exposure to late-stage disease and preventable complications—including diabetic amputations witnessed in practice—DTC was created on a simple conviction: early detection is not optional, it is a responsibility.
Today, DTC operates as a healthcare consulting firm, management services organization (MSO), program licensor, billing and implementation partner, and medical technology distributor.
DTC programs are available as licensed systems for medical groups, MSOs, ACOs, FQHCs, and healthcare entrepreneurs building chronic care networks. Through our License & Partnership Models, organizations can deploy the complete DTC chronic care pathway — including TriageIQ™, the full assessment suite, therapy programs, and implementation support — under a structured license designed for scale.
What We Do
DTC equips providers with rapid, non-invasive, CMS-aligned Chronic Risk Assessments and turnkey care programs designed to identify patient risk within the same visit—without adding staff, requiring construction, or disrupting existing workflows.
Our programs focus on the areas where chronic disease progresses silently and most often goes undetected:
Neurological Risk — cognitive decline, neuropathy, fall risk, sensory impairment, and diabetic retinopathy
Cardiometabolic Risk — peripheral artery disease (PAD), cardiovascular disease, autonomic dysfunction, and diabetes-related vascular damage
Behavioral Risk — depression, diabetes distress, sleep disorders, and adherence-related challenges
Pain-Related Risk —chronic foot pain may signal early neurovascular damage, and monitoring reduces wounds, amputations, and irreversible harm.
At the center of our model is TriageIQ™ a 1–2 minute Universal Chronic Screener that runs at every adult visit. It identifies early risk signals across all domains, establishes objective documentation, and supports medical necessity for further reimbursable assessments.
How It Works
Every DTC program follows a three-step pathway:
Screen — TriageIQ™ identifies patients who meet criteria for further assessment
Test — Rapid, non-invasive point-of-care diagnostics, each supported by CPT codes and CMS reimbursement guidelines
Treat — Turnkey programs with streamlined documentation, coding, and billing support
Clinics can operate up to 25 chronic care programs from a single room and launch in as little as 30 days—often with zero upfront capital—creating new clinical capabilities and revenue streams without operational strain.
The Impact
Early detection changes everything:
Up to 50% reduction in Alzheimer's risk
Up to 40% fewer amputations
Up to 30% fewer strokes and CHF cases
These are not just metrics—they represent parents, grandparents, and patients who get to return home healthier, avoid preventable complications, and live with dignity.
Daniel Medrano | Founder & CEO
Daniel Medrano is a healthcare visionary, strategist, and industry disruptor, reshaping preventive care with a rare blend of innovation, empathy, and scale. As Founder and CEO of Diabetes Testing Centers™ he is leading a national movement to modernize primary care—bringing AI-driven solutions, non-invasive diagnostics, and CPT-billable technologies directly into the hands of providers, where they can be most effective and fully reimbursable.
His mission was born in the operating room. Years before founding DTC, while working as a surgical representative, Daniel stood just feet away as a diabetic patient lost a lower limb. The moment was more than clinical, it was a tragedy decades in the making. Preventable, yet repeated in communities everywhere. The grief on the family’s faces and the knowledge that it didn’t have to happen ignited a fire in him that still burns.
Daniel’s career took him from pharmaceutical sales to nearly a decade in surgical devices, then to management in Johnson & Johnson’s Diabetes and Diagnostics Division. There, he saw a painful truth: innovation often stalled before it reached the front lines of care. The very tools that could save lives rarely made it into the hands of primary care providers, nurses, and caregivers—the people best positioned to change outcomes.
He left the security of corporate America to co-own a Family Practice and a Home Health company, trading boardrooms for exam rooms and patient homes. It was there that his mission became deeply personal. He saw frontline providers asked to do more with less, and families—especially in underserved communities, bearing the weight of preventable disease without adequate support. For Daniel, prevention stopped being a healthcare option. It became a moral obligation.
With a sharp grasp of both clinical workflows and payer systems, Daniel built DTC into a scalable ecosystem that now connects over 20,000 clinics nationwide with evidence-based, reimbursable assessments and therapies, removing the need for most specialist referrals. He empowers smaller clinics to outperform larger systems, replacing months-long waits with same-day answers.
His goal is not just to grow a company, it’s to make it unnecessary. In Daniel’s vision of success, diabetic amputations no longer happen, dialysis chairs sit empty, and families are spared the grief of losing loved ones to diseases that could have been caught in time. Until that vision becomes reality, his company stands as the most effective alternative, delivering the speed, precision, and compassion that larger healthcare systems too often leave behind.
Page updated
Report abuse